Oropharyngeal cancer treatment: The role of transoral surgery

Michael L. Hinni, Thomas Nagel, Brittany Howard

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Purpose of review This article reviews literature pertaining to squamous cell carcinoma (SCC) of the oropharynx and the evolution of transoral surgical (TOS) techniques for its management. Oncologists are recognizing a changing pattern in the cause of oropharyngeal cancer, namely the increasing incidence of HPV-associated tumors. An effort is underway to reduce the morbidity of treatment without jeopardizing survival. This is a timely discussion for reassessment of current standards of care and opening dialogue on treatment de-escalation. Transoral approaches including transoral laser microsurgery (TLM) and transoral robotic surgery (TORS) have revolutionized the surgical approach to SCC. Recent findings The incidence of HPV-related oropharyngeal SCC is increasing at epidemic rates. Although there are no studies comparing nonsurgical treatment to TOS in a randomized controlled fashion, there is an abundance of retrospective and prospective reports of TORS and TLM. Both early and advanced-stage oropharyngeal tumors can be managed successfully with surgery, with or without adjuvant therapy. Summary Although there are no hard scientific differences in oncologic outcomes between primary chemoradiation protocols and primary TOS-based approaches, retrospective comparisons support an advantage of primary surgery. In addition, functional outcomes may be superior following TOS treatment. Management of oropharyngeal SCC will most likely continue to be multidisciplinary with an ongoing effort to de-escalate treatment to reduce morbidity.

Original languageEnglish (US)
Pages (from-to)132-138
Number of pages7
JournalCurrent Opinion in Otolaryngology and Head and Neck Surgery
Volume23
Issue number2
DOIs
StatePublished - Jan 1 2015

Fingerprint

Oropharyngeal Neoplasms
Squamous Cell Carcinoma
Microsurgery
Robotics
Therapeutics
Morbidity
Oropharynx
Incidence
Laser Therapy
Standard of Care
Neoplasms
Lasers

Keywords

  • Oropharynx
  • Squamous cell carcinoma
  • Transoral laser microsurgery
  • Transoral robotic surgery
  • Transoral surgery

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery
  • Medicine(all)

Cite this

Oropharyngeal cancer treatment : The role of transoral surgery. / Hinni, Michael L.; Nagel, Thomas; Howard, Brittany.

In: Current Opinion in Otolaryngology and Head and Neck Surgery, Vol. 23, No. 2, 01.01.2015, p. 132-138.

Research output: Contribution to journalArticle

Hinni, Michael L. ; Nagel, Thomas ; Howard, Brittany. / Oropharyngeal cancer treatment : The role of transoral surgery. In: Current Opinion in Otolaryngology and Head and Neck Surgery. 2015 ; Vol. 23, No. 2. pp. 132-138.
@article{2b34869bbbf54c7da875971d22249c43,
title = "Oropharyngeal cancer treatment: The role of transoral surgery",
abstract = "Purpose of review This article reviews literature pertaining to squamous cell carcinoma (SCC) of the oropharynx and the evolution of transoral surgical (TOS) techniques for its management. Oncologists are recognizing a changing pattern in the cause of oropharyngeal cancer, namely the increasing incidence of HPV-associated tumors. An effort is underway to reduce the morbidity of treatment without jeopardizing survival. This is a timely discussion for reassessment of current standards of care and opening dialogue on treatment de-escalation. Transoral approaches including transoral laser microsurgery (TLM) and transoral robotic surgery (TORS) have revolutionized the surgical approach to SCC. Recent findings The incidence of HPV-related oropharyngeal SCC is increasing at epidemic rates. Although there are no studies comparing nonsurgical treatment to TOS in a randomized controlled fashion, there is an abundance of retrospective and prospective reports of TORS and TLM. Both early and advanced-stage oropharyngeal tumors can be managed successfully with surgery, with or without adjuvant therapy. Summary Although there are no hard scientific differences in oncologic outcomes between primary chemoradiation protocols and primary TOS-based approaches, retrospective comparisons support an advantage of primary surgery. In addition, functional outcomes may be superior following TOS treatment. Management of oropharyngeal SCC will most likely continue to be multidisciplinary with an ongoing effort to de-escalate treatment to reduce morbidity.",
keywords = "Oropharynx, Squamous cell carcinoma, Transoral laser microsurgery, Transoral robotic surgery, Transoral surgery",
author = "Hinni, {Michael L.} and Thomas Nagel and Brittany Howard",
year = "2015",
month = "1",
day = "1",
doi = "10.1097/MOO.0000000000000143",
language = "English (US)",
volume = "23",
pages = "132--138",
journal = "Current Opinion in Otolaryngology and Head and Neck Surgery",
issn = "1068-9508",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Oropharyngeal cancer treatment

T2 - The role of transoral surgery

AU - Hinni, Michael L.

AU - Nagel, Thomas

AU - Howard, Brittany

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose of review This article reviews literature pertaining to squamous cell carcinoma (SCC) of the oropharynx and the evolution of transoral surgical (TOS) techniques for its management. Oncologists are recognizing a changing pattern in the cause of oropharyngeal cancer, namely the increasing incidence of HPV-associated tumors. An effort is underway to reduce the morbidity of treatment without jeopardizing survival. This is a timely discussion for reassessment of current standards of care and opening dialogue on treatment de-escalation. Transoral approaches including transoral laser microsurgery (TLM) and transoral robotic surgery (TORS) have revolutionized the surgical approach to SCC. Recent findings The incidence of HPV-related oropharyngeal SCC is increasing at epidemic rates. Although there are no studies comparing nonsurgical treatment to TOS in a randomized controlled fashion, there is an abundance of retrospective and prospective reports of TORS and TLM. Both early and advanced-stage oropharyngeal tumors can be managed successfully with surgery, with or without adjuvant therapy. Summary Although there are no hard scientific differences in oncologic outcomes between primary chemoradiation protocols and primary TOS-based approaches, retrospective comparisons support an advantage of primary surgery. In addition, functional outcomes may be superior following TOS treatment. Management of oropharyngeal SCC will most likely continue to be multidisciplinary with an ongoing effort to de-escalate treatment to reduce morbidity.

AB - Purpose of review This article reviews literature pertaining to squamous cell carcinoma (SCC) of the oropharynx and the evolution of transoral surgical (TOS) techniques for its management. Oncologists are recognizing a changing pattern in the cause of oropharyngeal cancer, namely the increasing incidence of HPV-associated tumors. An effort is underway to reduce the morbidity of treatment without jeopardizing survival. This is a timely discussion for reassessment of current standards of care and opening dialogue on treatment de-escalation. Transoral approaches including transoral laser microsurgery (TLM) and transoral robotic surgery (TORS) have revolutionized the surgical approach to SCC. Recent findings The incidence of HPV-related oropharyngeal SCC is increasing at epidemic rates. Although there are no studies comparing nonsurgical treatment to TOS in a randomized controlled fashion, there is an abundance of retrospective and prospective reports of TORS and TLM. Both early and advanced-stage oropharyngeal tumors can be managed successfully with surgery, with or without adjuvant therapy. Summary Although there are no hard scientific differences in oncologic outcomes between primary chemoradiation protocols and primary TOS-based approaches, retrospective comparisons support an advantage of primary surgery. In addition, functional outcomes may be superior following TOS treatment. Management of oropharyngeal SCC will most likely continue to be multidisciplinary with an ongoing effort to de-escalate treatment to reduce morbidity.

KW - Oropharynx

KW - Squamous cell carcinoma

KW - Transoral laser microsurgery

KW - Transoral robotic surgery

KW - Transoral surgery

UR - http://www.scopus.com/inward/record.url?scp=84937878342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937878342&partnerID=8YFLogxK

U2 - 10.1097/MOO.0000000000000143

DO - 10.1097/MOO.0000000000000143

M3 - Article

C2 - 25761152

AN - SCOPUS:84937878342

VL - 23

SP - 132

EP - 138

JO - Current Opinion in Otolaryngology and Head and Neck Surgery

JF - Current Opinion in Otolaryngology and Head and Neck Surgery

SN - 1068-9508

IS - 2

ER -